Maple syrup urine disease (MSUD) is a rare inherited condition in which the body cannot properly break down three specific amino acids found in protein. These amino acids, leucine, isoleucine, and valine, accumulate to toxic levels in the blood and brain, giving urine and earwax a distinctive sweet smell resembling maple syrup. It affects roughly 1 in 185,000 newborns worldwide, though certain populations carry the condition at dramatically higher rates.
What Causes MSUD
Every time you eat protein, your body breaks it into amino acids and then processes them further for energy or building materials. Three of those amino acids, called branched-chain amino acids, require a specific enzyme complex (BCKD) to be broken down. In MSUD, genetic mutations disrupt parts of this enzyme complex so that it either works poorly or not at all.
The condition is autosomal recessive, meaning a child must inherit a faulty copy of the gene from both parents. Several different genes can be responsible, each coding for a different piece of the enzyme complex. When any critical piece is missing or malformed, leucine, isoleucine, and valine pile up in the bloodstream. The buildup is particularly toxic to the nervous system, which is why untreated MSUD causes severe brain damage.
Who Is Most at Risk
Because MSUD requires two copies of a defective gene, it’s more common in communities where people tend to marry within a smaller genetic pool. Among Old Order Mennonites of eastern Pennsylvania, classic MSUD occurs in approximately 1 in 176 births, making it over a thousand times more common than in the general population. A California newborn screening study covering more than 2.2 million births between 2005 and 2010 also found higher rates in individuals of Middle Eastern ancestry (about 14 per 100,000 births) and Filipino ancestry (about 2 per 100,000), while most other ethnic groups fell below 1 per 100,000.
Signs in Newborns
Babies with classic MSUD appear normal at birth. Symptoms typically emerge between 3 and 7 days of life, once the infant has been taking in breast milk or formula and protein breakdown products start to accumulate. Breastfed babies sometimes develop symptoms a bit later, into the second week, because breast milk comes in gradually.
Early warning signs include poor feeding, increasing sleepiness or lethargy, fussiness, vomiting, and weak or unusual muscle tone. Some infants develop a high-pitched cry or seizures. The hallmark sign is a sweet, maple syrup-like odor in the urine, which becomes more noticeable after it dries in a diaper. Not every parent will notice the smell right away, which is one reason newborn screening programs are so important for catching the condition early.
How MSUD Is Diagnosed
In the United States and many other countries, MSUD is part of the standard newborn screening panel. A small blood sample collected from a heel prick within the first day or two of life can detect elevated levels of branched-chain amino acids. If that initial screen comes back abnormal, follow-up testing measures the precise blood levels of leucine, isoleucine, and valine.
One amino acid in particular, alloisoleucine, serves as a definitive marker. It is essentially absent in healthy individuals but appears at significant levels in people with MSUD, making it a reliable confirmation tool. Diagnosis typically involves measuring either the individual amino acid concentrations or a combined total that includes leucine, isoleucine, and alloisoleucine together.
Lifelong Dietary Management
The core treatment for MSUD is a carefully controlled diet that limits branched-chain amino acids while still providing enough nutrition for normal growth and brain development. This diet is not temporary. It must be followed for life.
In infancy, this means using specially manufactured formulas that contain all essential amino acids except leucine, isoleucine, and valine. Small, precisely measured amounts of regular breast milk or standard formula are added to provide just enough of those three amino acids for healthy development without letting levels climb into the danger zone. Each child’s leucine allowance is calculated individually based on regular blood tests.
As children grow, the diet expands to include measured portions of natural protein from foods like vegetables, cheese, and dairy products, combined with protein-free specialty products and amino acid supplements. Clinical guidelines recommend keeping plasma leucine between 75 and 200 micromoles per liter for infants and children under five, and between 75 and 300 for older children and adults. Staying within these ranges is associated with better cognitive outcomes. Research has shown that this carefully managed diet does not, on average, compromise body composition, with patients maintaining normal fat and lean mass.
The practical reality is constant vigilance. Families learn to calculate the protein content of every meal, and routine blood draws are a regular part of life. Any illness, even a common cold, can trigger a spike in amino acid levels because the body breaks down its own muscle protein during stress and fasting. These episodes, called metabolic crises, require urgent medical attention to bring amino acid levels back down before brain damage occurs.
Liver Transplantation as a Potential Cure
Because the liver is where most branched-chain amino acid processing happens, a liver transplant can effectively cure the metabolic instability of MSUD. The transplanted liver provides a working copy of the enzyme complex that the patient’s own body cannot make.
Results have been striking. In a study published in the American Journal of Transplantation, leucine, isoleucine, and valine levels stabilized within six hours after surgery and remained normal on a completely unrestricted protein diet. All patients in the study were alive and well at follow-up, with the longest-tracked patient showing normal metabolic function and psychomotor development more than eight years after transplant. After transplantation, patients tolerated normal protein intake, maintained stable amino acid levels even during illness, and achieved leucine processing rates of about 45% of what’s seen in healthy individuals, which proved more than sufficient.
Transplantation is not a simple decision, though. It carries the risks of any major organ surgery, including the need for lifelong anti-rejection medications. It is generally considered for patients who have frequent metabolic crises despite careful dietary management, or for families who struggle to maintain the intensive dietary regimen. For those who undergo the procedure successfully, the transformation is profound: the constant dietary calculations, emergency hospital visits, and fear of metabolic crises largely disappear.
Types of MSUD
Not all cases are equally severe. Classic MSUD is the most common and most dangerous form, with little to no enzyme activity and symptoms appearing in the first week of life. Intermediate and intermittent forms retain some enzyme function, meaning symptoms may not appear until later in childhood or may only surface during illness or periods of high protein intake. These milder variants can be harder to diagnose because the child may develop normally for months or years before a metabolic crisis reveals the underlying condition.
Regardless of type, all forms of MSUD carry the risk of a metabolic crisis during physical stress, surgery, or illness. Even people with milder variants need a management plan and medical team familiar with the condition.
Long-Term Outlook
With early detection through newborn screening and consistent dietary management, many people with MSUD lead full lives. The biggest predictor of long-term intellectual and neurological outcomes is how quickly treatment begins and how well amino acid levels are controlled during infancy and early childhood, when the brain is developing most rapidly. Delays in diagnosis or prolonged periods of elevated leucine can cause irreversible brain injury.
Children diagnosed and treated within the first week of life generally have significantly better outcomes than those identified later. Ongoing management requires a metabolic specialist, a dietitian experienced with inborn errors of metabolism, and a family prepared for the daily demands of a restricted diet. For those who achieve stable control, whether through diet alone or through transplantation, the prognosis has improved dramatically over the past few decades.